Foundry Partners, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$815,000
-15.9%
8,550
-1.3%
0.04%
-17.0%
Q2 2020$969,000
+48.2%
8,660
-3.7%
0.05%
+27.0%
Q1 2020$654,000
-30.2%
8,9890.0%0.04%
+5.7%
Q4 2019$937,000
+2.3%
8,989
-2.3%
0.04%
-7.9%
Q3 2019$916,000
-13.0%
9,203
-0.2%
0.04%
-7.3%
Q2 2019$1,053,000
-9.5%
9,224
-0.3%
0.04%
-12.8%
Q1 2019$1,163,000
+11.1%
9,251
+19.8%
0.05%
+113.6%
Q4 2018$1,047,0007,7190.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders